Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms.
Duarte DP, Lamontanara AJ, La Sala G, Jeong S, Sohn YK, Panjkovich A, Georgeon S, Kükenshöner T, Marcaida MJ, Pojer F, De Vivo M, Svergun D, Kim HS, Dal Peraro M, Hantschel O.
Duarte DP, et al. Among authors: lamontanara aj.
Nat Commun. 2020 May 8;11(1):2319. doi: 10.1038/s41467-020-16128-5.
Nat Commun. 2020.
PMID: 32385234
Free PMC article.